>> 全站文章索引 >> 第11页:
  • Increased Tonic Activation of Rat Forebrain 5-HT1A Receptors by Lithium Addition to Antidepressant Treatments - [Nasser Haddjeri Ph.D, Steven T Szabo BSc, Claude de Montigny MD, Ph.D and Pierre Blier MD, Ph.D]
  • Effects of Acute and Long-Term Administration of Escitalopram and Citalopram on Serotonin Neurotransmission: an In Vivo Electrophysiological Study in Rat Brain - [Mostafa El Mansari1,3, Connie Sánchez2, Guy Chouvet1, Bernard Renaud1 and Nasser Haddjeri1]
  • Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors - [Kazufumi Hirano1, Ryohei Kimura1, Yumi Sugimoto2, Jun Yamada2, Shinya Uchida3, Yasuhiro Kato4, Hisakuni Hashimoto4 and Shizuo Yamada1]
  • Cognitive-behavioral therapy for depression in Parkinson's disease A pilot study - [Dobkin RD, Allen LA, Menza M.]
  • Modifications in Brain CaM Kinase II after Long-Term Treatment with Desmethylimipramine - [E Consogno2 Ph.D, G Racagni1,2 Ph.D and M Popoli1,3 Ph.D]
  • Antidepressant-Like Effect of Different Estrogenic Compounds in the Forced Swimming Test - [Erika Estrada-Camarena1,2, Alonso Fernández-Guasti1 and Carolina López-Rubalcava1]
  • Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil - [L. Ferraro, K. Fuxe, S. Tanganelli, M. Fernandez, F. A. Rambert and T. Antonelli]
  • Expectation and Dopamine Release- Mechanism of the Placebo Effect in Parkinson's Disease - [de la Fuente-Fernández R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ.]
  • Non-aqueous capillary zone electrophoresis method for the analysis of paroxetine, tamoxifen, and their main metabolites in urine - [J. Rodríguez Flores, J. J. Berzas Nevado, A. M. Contento Salcedo and M. P. Cabello Díaz]
  • LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine2A receptor antagonist: a comparison with the antidepressant, nefazodone - [Ian A. Pullar, Stephen L. Carney, Ellen M. Colvin, Virginia L. Lucaites, David L. Nelson and Susan Wedley]
  • Pharmacological characterization of the serotonin transporter in young and elderly subjects. - [Marazziti D, Baroni S, Rossi A, Masala I, Giannaccini G, Gori V, Lucacchini A, Cassano GB]
  • Antidepressants and adverse effects in young patients: uncovering the evidencea - [Andrew Herxheimer, Barbara Mintzes]
  • No association between dopamine D2 and D4 receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors - [Alessandro Serretti, Raffaella Zanardi, Cristina Cusin, David Rossini, Roberta Lilli, Cristina Lorenzi, Enrico Lattuada and Enrico Smeraldi]
  • Tryptophan hydroxylase gene associated with paroxetine antidepressant activity - [Alessandro Serretti, Raffaella Zanardi, Cristina Cusin, David Rossini, Cristina Lorenzi and Enrico Smeraldi]
  • Do antidepressants affect motivation in conditioned place preference? - [Fazal Subhan, Paul N. Deslandes, David M. Pache and Robert D. E. Sewell]
  • Rescuing drug discovery: in vivo systems pathology and systems pharmacology - [van der Greef J, McBurney RN]
  • nnovation: Rescuing drug discovery: in vivo systems pathology and systems pharmacology - [Jan van der Greef, Robert N. McBurney]
  • Decreased lymphocyte 3H-paroxetine binding in obsessive-compulsive disorder - [D. Marazziti, S. Baroni, I. Masala, F. Mungai, E. Di Nasso and G. Giannaccini 319.]
  • Decreased lymphocyte (3)h-paroxetine binding in obsessive-compulsive disorder. - [Marazziti D, Baroni S, Masala I, Giannaccini G, Mungai F, Di Nasso, Cassano GB]
  • Obsession in the Strict Sense-A Helpful Psychopathological Phenomenon in the Differential Diagnosis between Obsessive-Compulsive Disorder and Schizophrenia - [M. Bürgy]
  • Obsession in the Strict Sense:A Helpful Psychopathological Phenomenon in the Differential Diagnosis between Obsessive-Compulsive Disorder and Schizophrenla - [Bürgy M.]
  • Obsession in the Strict Sense A Helpful Psychopathological Phenomenon in the Differential Diagnosis between Obsessive-Compulsive Disorder and Schizophrenia - [Bürgy M.]
  • Efficacy studies of paroxetine in panic disorder. - [Lydiard RB, Steiner M, Burnham D, Gergel I]
  • Responsiveness of 5-HT(1A) and 5-HT(2) receptors in the rat orbitofrontal cortex after long-term serotonin reuptake inhibition. - [El Mansari M, Blier P]
  • Serotonin 2A -1438 G/A and G-Protein Beta3 Subunit C825T Polymorphisms in Patients with Depression and SSRI-Associated Sexual Side-Effects - [Jeffrey R Bishop1, Jessica Moline2, Vicki L Ellingrod2, Susan K Schultz3 and Anita H Clayton4]
  • Usefulness of Paroxetine in Depressed Men With Paroxysmal Atrial Fibrillation - [Takeshi Shirayama, Takashi Sakamoto, Tomohiko Sakatani, Hiroki Mani, Taku Yamamoto and Hiroaki Matsubara]
  • Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation - [I A Abdel-Hamid, E A El Naggar, A-H El Gilany]
  • Impact of prior treatment exposure on response to antidepressant treatment in late life. - [Tew JD Jr, Mulsant BH, Houck PR, Lenze EJ, Whyte EM, Miller MD, Stack JA, Bensasi S, Reynolds CF 3rd]
  • Are There Two Depressive Syndromes after Stroke - [MORRIS, P. HILIP; SHIELDS, R. OBERT; HOPWOOD, M. ALCOLM; ROBINSON, R. OBERT; RAPHAEL, B. EVERLEY]
  • Paroxetine for social anxiety and alcohol use in dual-diagnosed patients - [Carrie L. Randall, Ph.D. 1 *, Michael R. Johnson, M.D. 1, Angelica K. Thevos, Ph.D. 1, Susan C. Sonne, Pharm.D. 1, Suzanne E. Thomas, Ph.D. 1, Shauna L. Willard, M.A. 1, Kathleen T. Brady, M.D., Ph.D. 1, Jonathan R. Davidson, M.D. 2 AD:1Alcohol Research C]
  • Cognitive Function Impairment in Patients with Neuropathic Pain Under Standard Conditions of Care - [Povedano M, Gascón J, Gálvez R, Ruiz M, Rejas J.]
  • Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders - [M K Hahn and R D Blakely]
  • Changes of Sleep Architecture, Spectral Composition of Sleep EEG, the Nocturnal Secretion of Cortisol, ACTH, GH, Prolactin, Melatonin, Ghrelin, and Leptin, and the DEX-CRH Test in Depressed Patients during Treatment with Mirtazapine - [Dagmar A Schmid1, Adam Wichniak1, Manfred Uhr1, Marcus Ising1, Hans Brunner1, Katja Held1, Jutta C Weikel1, Annette Sonntag1 and Axel Steiger1]
  • Carnosine prevents methamphetamine-induced gliosis but not dopamine terminal loss in rats - [David Pubill, Ester Verdaguer, Francesc X. Sureda, Antoni Camins, Mercè Pallàs, Jordi Camarasa and Elena Escubedo]
  • Substance P in serum and cerebrospinal fluid of depressed patients: No effect of antidepressant treatment - [Michael Deuschle, Peter Sander, Inga Herpfer, Bernd L. Fiebich, Isabella Heuser and Klaus Lieb]
  • Coupling of human nicotinic acetylcholine receptors α7 to calcium channels in GH3 cells - [Dominik Feuerbach, Kurt Lingenh?hl, Peter Dobbins, Johannes Mosbacher, Nicola Corbett, Joachim Nozulak and Daniel Hoyer]
  • Reduction of Hypothalamic Vasopressinergic Hyperdrive Contributes to Clinically Relevant Behavioral and Neuroendocrine Effects of Chronic Paroxetine Treatment in a Psychopathological Rat Model - [Martin E Keck, Tobias Welt, Marianne B Müller, Manfred Uhr, Frauke Ohl, Alexandra Wigger, Nicola Toschi, Florian]
  • NAMS releases position statement on the treatment of vasomotor symptoms associated with menopause. - [Neff MJ]
  • Multifunctional drugs with different CNS targets for neuropsychiatric disorders - [Van der Schyf CJ, Geldenhuys WJ, Youdim MB.]
  • Paroxetine must not be given to patients under 18 - [Fabian Waechter]
  • Antidepressant drug treatment induces Arc gene expression in the rat brain - [Q. Pei, T. S. C. Zetterstr?m, M. Sprakes, R. Tordera and T. Sharp]
  • Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania - [V De Luca1, E Mundo1,2, J Trakalo1, G W H Wong1 and J L Kennedy1]
  • SSRIs in the Treatment of obsessive-compulsive disorder - [Charles Cartwright, M.D., Eric Hollander, M.D. * AD:Mount Sinai School of Medicine, New York, New York]
  • The pharmacogenomics of selective serotonin reuptake inhibitors - [A Serretti1 and P Artioli1]
  • The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors ? ARTICLE - [Fenghua Chen, Mads Breum Larsen, Connie Sánchez and Ove Wiborg]
  • Liquid Courage- Alcohol Fosters Risky Sexual Decision-Making in Individuals with Sexual Fears - [Stoner SA, George WH, Peters LM, Norris J.]
  • Genetic and Environmental Effects on Complex Traits in Mice - [Valdar W, Solberg LC, Gauguier D, Cookson WO, Rawlins JN, Mott R, Flint J.]
  • Potentiation by (-)Pindolol of the Activation of Postsynaptic 5-HT1A Receptors Induced by Venlafaxine - [Jean-Claude Bé?que Ph.D, Pierre Blier MD, Ph.D, Claude de Montigny MD, Ph.D and Guy Debonnel MD]
  • Selective Serotonin Reuptake Inhibitors Decrease Impulsive Behavior as Measured by an Adjusting Delay Procedure in the Pigeon - [Mary C Wolff MA and J David Leander Ph.D]
  • Pharmacogenomic Evaluation of the Antidepressant Citalopram in the Mouse Tail Suspension Test - [James J Crowley1, Edward S Brodkin2, Julie A Blendy1, Wade H Berrettini1,2 and Irwin Lucki1,2]
  • Fluoxetine and Sleep EEG: Effects of a Single Dose, Subchronic Treatment, and Discontinuation in Healthy Subjects - [Bernd Feige1 Ph.D, Ulrich Voderholzer1 MD, Dieter Riemann1 Ph.D, Professor, Ralf Dittmann2 MD, Ph.D, Fritz Hohagen1 MD, Professor and Mathias Berger1 MD, Professor]
  • Paroxetine treatment of primary insomnia in older adults. - [Reynolds CF 3rd, Buysse DJ, Miller MD, Pollock BG, Hall M, Mazumdar S]
  • Differential effects of antidepressants on dexamethasone-induced nuclear translocation and expression of glucocorticoid receptor - [Hiromasa Funato, Ayumi Kobayashi and Yoshifumi Watanabe]
  • Bi-phasic change in BDNF gene expression following antidepressant drug treatment - [A. L. Coppell, Q. Pei and T. S. C. Zetterstr?m]
  • The functional anxtomy neurochemistry,and pgarmacology of anxiety - [Ninan PT.]
  • Methylphenidate ('Ritalin') can Ameliorate Abnormal Risk-Taking Behavior in the Frontal Variant of Frontotemporal Dementia - [Shibley Rahman1, Trevor W Robbins2, John R Hodges3,4, Mitul A Mehta5, Peter J Nestor3, Luke Clark2 and Barbara J Sahakian1]
  • The four-plates test: Anxiolytic or analgesic paradigm? - [Nadège Ripoll, Martine Hasco?t and Michel Bourin]
  • Pharmacokinetics of selective serotonin reuptake inhibitors - [Christoph Hiemke and Sebastian H?rtter]
  • Genomic organization of the SLC1A1/EAAC1 gene and mutation screening in early-onset obsessive-compulsive disorder - [J Veenstra-VanderWeele1, S-J Kim1, D Gonen1, G L Hanna2, B L Leventhal1,3 and E H Cook Jr1,3]
  • Lifestyle drugs: Issues for debate - [Joel Lexchin]
  • Paroxetine approved for generalized anxiety - [Monica Preboth]
  • The Flawed Basis for FDA Post-Marketing Safety Decisions， The Example of Anti-Depressants and Children - [Klein DF.]
  • Neuropsychopharmacology (2006) 31, 689–699. doi:10.1038/sj.npp.1300996; published online 14 December 2005 - [Donald F Klein1]
  • Exposure assessment and microcosm fate of selected selective serotonin reuptake inhibitors - [David J. Johnson, Hans Sanderson, Richard A. Brain, Christian J. Wilson, Ketut (Jim) T. Bestari and Keith R. Solomon]
  • New antidepressants for old people? - [Martin G Livingston, Hilary M Livingston]
  • Serotonin Function in Panic Disorder: Important, But Why? - [Eduard Maron1 and Jakov Shlik2]
  • Enzymatic production of (3S,4R)-(?)-4-(4′-fluorophenyl)-6-oxo-piperidin-3-carboxylic acid using a commercial preparation from Candida antarctica A: the role of a contaminant esterase - [Jose M. Palomo, Gloria Fernández-Lorente, Cesar Mateo, Manuel Fuentes, Jose M. Guisan and Roberto Fernández-Lafuente]
  • Enzymatic resolution of (±)-trans-4-(4′-fluorophenyl)-6-oxo-piperidin-3-ethyl carboxylate, an intermediate in the synthesis of (?)-Paroxetine - [Jose M. Palomo, Gloria Fernández-Lorente, Cesar Mateo, Roberto Fernández-Lafuente and José M. Guisan]
  • Lifelong premature ejaculation: definition, serotonergic neurotransmission and drug treatment - [Marcel D. Waldinger]
  • Progress report on new antiepileptic drugs-A summary of the Eigth Eilat Conference (EILAT VIII) - [Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T.]
  • CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. - [Jin Y, Desta Z, Stearns V, Ward B, Ho H, Lee KH, Skaar T, Storniolo AM, Li L, Araba A, Blanchard R, Nguyen A,]
  • Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: Evidence for synergism between serotonergic and noradrenergic reuptake inhibition - [Carrie K. Jones, Brian J. Eastwood, Anne B. Need and Harlan E. Shannon]
  • Demonstration of the Efficacy and Safety of a Novel Substance P(NK1) Receptor Antagonist in Major Depression - [Mark S Kramer1,2, Andrew Winokur3, Jeffrey Kelsey4, Sheldon H Preskorn5,6, Anthony J Rothschild7, Duane Snavely1, Kalyan Ghosh1, William A Ball1, Scott A Reines1, Dennis Munjack8, Jeffrey T Apter9, Lynn Cunningham10, Mitchel Kling11, Mohammed Bari12, Albe]
  • emonstration of the Efficacy and Safety of a Novel Substance P (NK1) Receptor Antagonist in Major Depression - [Kramer MS, Winokur A, Kelsey J, Preskorn SH, Rothschild AJ, Snavely D, Ghosh K, Ball WA, Reines SA, Munjack D, Apter JT, Cunningham L, Kling M, Bari M, Getson A, Lee Y.]
  • The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT1B receptor knockout mice - [Lotte De Groote, Berend Olivier and Herman G. M. Westenberg]
  • Strain-dependent modification of behavior following antidepressant treatment - [Shanaz Tejani-Butt, Joseph Kluczynski and William P. Paré]
  • Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat - [Jean-Claude Bé?que, Claude de Montigny, Pierre Blier and Guy Debonnel]
  • Acute effects of amperozide and paroxetine on social cohesion in male conspecifics - [David J. Rademacher, Anthony P. Anderson and Rhea E. Steinpreis]
  • Impact of a collaborative pharmacy practice model on the treatment of depression in primary care - [Dr. P.R. Finley, Univ. of California at San Francisco, 521 Parnassus Avenue, San Francisco, CA 94143-0622; United States.]
  • Pindolol potentiation of paroxetine for generalized social phobia: A double-blind, placebo-controlled, crossover study - [Murray B Stein, Jitender Sareen, Shadha Hami, Jeffrey Chao.]
  • Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats - [Miki Yamauchi, Tomoko Tatebayashi, Kinuko Nagase, Maho Kojima and Taiichiro Imanishi]
  • Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine - [S. C. Cheetham, J. A. Viggers, N. A. Slater and D. J. Heal]
  • Evaluation of the neuropharmacodynamics of paroxetine in vivo utilizing microdialysis - [Atulkumar Ramaiya 1, James H. Johnson 2, H. Thomas Karnes 1 * AD:1Department of Pharmacy & Pharmaceutics, Medical College of Virginia/Virginia Commonwealth University, P.O. Box 980533, Richmond, Virginia 23298-980533.2Department of Anatomy, Medical Colleg]
  • Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia - [Bender S, Weisbrod M, Resch F.]
  • Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia - [Bender S, Weisbrod M, Resch F.]
  • Maternal anxiety- course and antecedents during the early postpartum period - [Britton JR.]
  • Maternal anxiety course and antecedents during the early postpartum period - [Britton JR.]
  • Drug company experts advised staff to withhold data about SSRI use in children - [Wayne Kondro, Barbara Sibbald]
  • Treating major depression in primary care practice: An update of the agency for health care policy and research practice guidelines - [Dr. H.C. Schulberg, Western Psychiatric Inst. and Clinic, 3811 O]
  • Age-Dependent Reductions in the Level of Glial Fibrillary Acidic Protein in the Prefrontal Cortex in Major Depression - [Xiaohong Si, Jose Javier Miguel-Hidalgo, Gillian O]
  • Multiple Dose Pharmacokinetics of Paroxetine in Children and Adolescents with Major Depressive Disorder or Obsessive–Compulsive Disorder - [Robert L Findling1, Gianluca Nucci2, Antoni A Piergies3, Roberto Gomeni2, Edward I Bartolic4, Regan Fong5, David J Carpenter5, J Steven Leeder6, Andrea Gaedigk6 and Theodore M Danoff5]
  • Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution: A fluorine MRS study - [Michael E Henry, Constance M Moore, Marc J Kaufman, David Michelson, et al]
  • Genetics of suicide - [B Bondy1, A Buettner2 and P Zill1]
  • Compulsive Voyeurism and Exhibitionism: A Clinical Response to Paroxetine - [Ahmed Abouesh, Anita Clayton]
  • The clinical response to total sleep deprivation and recovery sleep in geriatric depression: potential indicators of antidepressant treatment outcome - [Cameron R. Hernandez, Gwenn S. Smith, Patricia R. Houck, Bruce G. Pollock, Benoit Mulsant, Mary Amanda Dew and Charles F. Reynolds III]
  • Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine - [éva Hajós-Korcsok, Sarah F. B. McTavish and Trevor Sharp]
  • PLASMA MEMBRANE MONOAMINE TRANSPORTERS: STRUCTURE, REGULATION AND FUNCTION - [Gonzalo E. Torres, Raul R. Gainetdinov & Marc G. Caron about the authors]
  • Enantiomeric analysis of (3S,4R)-4-(4-fluorophenyl)- 3-hydroxymethyl-1-methylpiperidine by 19F NMR spectroscopy - [Hana Navrátilová * AD:Department of Organic Chemistry, Faculty of Science, Masaryk University, 611 37 Brno, Czech Republic]
  • The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression - [A Szegedi1, D Rujescu2, A Tadic3, M J Müller3, R Kohnen4, H H Stassen5 and N Dahmen3]
  • Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder - [Strawn JR, Geracioti TD]


    • 分页: 1 2 3 4 5 6 7 8 9 10 [11] 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
    41 42 43 44 45 46 47 48 49 50